Journal of Contemporary Brachytherapy

Journal of Contemporary Brachytherapy

The “Journal of Contemporary Brachytherapy” is an international and multidisciplinary journal that will publish papers of original research as well as reviews of articles. Main subjects of the journal include: clinical brachytherapy, combined modality treatment, advances in radiobiology, hyperthermia and tumour biology, as well as physical aspects relevant to brachytherapy, particularly in the field of imaging, dosimetry and radiation therapy planning. Original contributions will include experimental studies of combined modality treatment, tumor sensitization and normal tissue protection, molecular radiation biology, and clinical investigations of cancer treatment in brachytherapy. Another field of interest will be the educational part of the journal.

The “Journal of Contemporary Brachytherapy” publish original peer-reviewed papers, technical advances, reviews of articles, and point/counterpoint of opinions on controversial issues. Original articles regarding any aspect of brachytherapy always are welcome. Educational papers will be prepared and presented by invited authors. Letters to the Editor-in-Chief are highly encouraged.

The journal is originally published in the print version.

IMPACT FACTOR
1.5
MNiSW
70
JCI (Journal Citation Indicator)
0.32
Cite Score
2.4
without publication fees
SCImago Journal & Country Rank


Current issue

2/2026 vol. 18
 
article image

Editorial

J Contemp Brachytherapy 2026; 18, 2

View text
Magnetic resonance imaging-guided salvage high-dose-rate brachytherapy for local recurrence after prostatectomy and external beam radiotherapy

Original paper

J Contemp Brachytherapy 2026; 18, 2: 117–123

DOI: https://doi.org/10.5114/jcb.2026.162242
Abstract View text (PDF)
Efficacy of peri-operative high-dose-rate interstitial brachytherapy in keloids: Can we scare the bad scar?

Original paper

J Contemp Brachytherapy 2026; 18, 2: 124–130

DOI: https://doi.org/10.5114/jcb.2026.161350
Abstract View text (PDF)
Ruthenium-106 ocular surface brachytherapy for incompletely excised conjunctival melanoma and squamous cell carcinoma

Original paper

J Contemp Brachytherapy 2026; 18, 2: 131–137

DOI: https://doi.org/10.5114/jcb.2026.162466
Abstract View text (PDF)
Fractionated stereotactic re-irradiation after plaque radiotherapy (brachytherapy) failure in uveal melanoma

Original paper

J Contemp Brachytherapy 2026; 18, 2: 138–141

DOI: https://doi.org/10.5114/jcb.2026.161861
Abstract View text (PDF)
The value of pre-brachytherapy MRI in aiding applicator selection for cervical cancer procedures

Original paper

J Contemp Brachytherapy 2026; 18, 2: 142–146

DOI: https://doi.org/10.5114/jcb.2026.163306
Abstract View text (PDF)
Outcomes of cervical carcinoma patients treated with chemoradiation and single-application two-fractions schedule of high-dose-rate brachytherapy: A retrospective review (SATF study)

Original paper

J Contemp Brachytherapy 2026; 18, 2: 154–162

DOI: https://doi.org/10.5114/jcb.2026.163310
Abstract View text (PDF)
Automated planning in image-guided adaptive brachytherapy for cervical cancer: Impact analysis on patient workflows in high-volume centers

Original paper

J Contemp Brachytherapy 2026; 18, 2: 163–170

DOI: https://doi.org/10.5114/jcb.2026.163311
Abstract View text (PDF)
Can image-guided external beam radiotherapy boost be an alternative when intracavitary brachytherapy is unavailable for locally advanced cervical cancer? A dosimetric analysis and literature review

Original paper

J Contemp Brachytherapy 2026; 18, 2: 171–178

DOI: https://doi.org/10.5114/jcb.2026.163312
Abstract View text (PDF)
Iridium-192 high-dose-rate calibration discrepancies: A growing concern?

Original paper

J Contemp Brachytherapy 2026; 18, 2: 179–186

DOI: https://doi.org/10.5114/jcb.2026.163313
Abstract View text (PDF)
Development of a patient-specific adaptive ring for organ at risk contours in high-dose-rate brachytherapy gynecologic cancers

Original paper

J Contemp Brachytherapy 2026; 18, 2: 187–195

DOI: https://doi.org/10.5114/jcb.2026.162464
Abstract View text (PDF)
Automated EQD2 reporting for cervical cancer high-dose-rate brachytherapy using a standalone ESAPI-based application

Original paper

J Contemp Brachytherapy 2026; 18, 2: 196–203

DOI: https://doi.org/10.5114/jcb.2026.162294
Abstract View text (PDF)
Hybrid adjuvant therapy with 3D-printed orbital brachytherapy and stereotactic body radiotherapy for recurrent adenoid cystic carcinoma: A technical note

Original paper

J Contemp Brachytherapy 2026; 18, 2: 204–211

DOI: https://doi.org/10.5114/jcb.2026.163317
Abstract View text (PDF)